CXORF56 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.288600420286E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.26810000000444E-05 |
Normal-vs-Stage2 |
1.70225999999163E-05 |
Normal-vs-Stage3 |
1.10640385742045E-11 |
Normal-vs-Stage4 |
9.19359999240754E-09 |
Stage1-vs-Stage2 |
4.049800E-02 |
Stage1-vs-Stage3 |
3.58609999995263E-06 |
Stage1-vs-Stage4 |
8.816500E-04 |
Stage2-vs-Stage3 |
2.274800E-01 |
Stage2-vs-Stage4 |
3.290200E-01 |
Stage3-vs-Stage4 |
8.858600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.16130002783643E-10 |
Normal-vs-AfricanAmerican |
3.87809999999877E-05 |
Normal-vs-Asian |
5.775400E-01 |
Caucasian-vs-AfricanAmerican |
8.734800E-01 |
Caucasian-vs-Asian |
2.668400E-01 |
AfricanAmerican-vs-Asian |
2.577800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.02149955161224E-10 |
Normal-vs-Female |
4.59150000020614E-07 |
Male-vs-Female |
1.735800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.249080E-04 |
Normal-vs-Age(41-60Yrs) |
9.37090000041607E-08 |
Normal-vs-Age(61-80Yrs) |
1.11190001650385E-09 |
Normal-vs-Age(81-100Yrs) |
6.995700E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.591010E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.498000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.186000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.259200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.051800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.068400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.981400E-01 |
Normal-vs-Grade 2 |
4.03090000000716E-05 |
Normal-vs-Grade 3 |
1.75920389366979E-11 |
Normal-vs-Grade 4 |
3.34330008122663E-10 |
Grade 1-vs-Grade 2 |
9.686100E-02 |
Grade 1-vs-Grade 3 |
5.435900E-03 |
Grade 1-vs-Grade 4 |
1.722600E-03 |
Grade 2-vs-Grade 3 |
6.824900E-04 |
Grade 2-vs-Grade 4 |
1.8560799999956E-05 |
Grade 3-vs-Grade 4 |
5.858100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.156600E-03 |
Normal-vs-ccB subtype |
3.98681088142894E-13 |
ccA subtype-vs-ccB subtype |
3.62890000271676E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.97790003767062E-09 |
Normal-vs-N1 |
4.20640000053929E-07 |
N0-vs-N1 |
9.182000E-02 |
|
|